久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Study links anti-malaria drug to higher death risk

By AI HEPING in New York | China Daily | Updated: 2020-05-25 09:47
Share
Share - WeChat
Researcher Cody Hoffmann checks the results of an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of coronavirus disease (COVID-19) at the University of Minnesota in Minneapolis, Minnesota, US, March 19, 2020. [Photo/Agencies]

A study of 96,000 hospitalized coronavirus patients who received the anti-malaria drug being taken by US President Donald Trump to guard against getting the coronavirus found that those who received the drug were more likely to have abnormal heart rhythms and were more likely to die, according to a study published on Friday in the medical journal The Lancet.

The study's authors recommended that hydroxychloroquine, and the closely related drug chloroquine, shouldn't be used to treat patients outside of clinical trials, as they found it didn't benefit people suffering from COVID-19.

The study is the largest analysis to date of the risks and benefits of treating COVID-19 patients with anti-malaria drugs. It is based on data from 96,032 coronavirus patients from 671 hospitals around the world.

Observational studies like this one can't provide definitive evidence about drug safety and effectiveness. But the authors of the study recommended that the drugs not be used outside clinical trials, and they said carefully controlled trials were urgently needed. Several clinical trials are under way around the world.

Trump has hailed hydroxychloroquine as a "game-changer" for COVID-19. He said last week he was taking it as a preventive measure against the disease. He has since said he is close to finishing his course of treatment and would stop taking the medication in "a day or two".

Past studies also haven't supported hydroxychloroquine's benefit for treating sick patients, and there have been reports of dangerous heart problems associated with its use. The US Food and Drug Administration, or FDA, last month warned against the use of the drug outside hospital settings or clinical trials.

'Another nail in the coffin'

Peter Lurie, a former top FDA official who now heads the Center for Science in the Public Interest, told The Washington Post that the study is "another nail in the coffin for hydroxychloroquine-this time from the largest study ever".

The new study's findings cannot necessarily be extrapolated to people with mild illness at home or those, like Trump, who are taking the anti-malarials as a prophylactic. The president stunned many doctors earlier last week when he said he was taking a pill "every day".

There have been at least 13 studies in recent months on hydroxychloroquine or chloroquine as a treatment for COVID-19 patients. They have included randomized controlled studies and observational analyses encompassing patients on the continuum from mild illness to those near death. Evidence of any benefit, such as viral clearance or improved symptoms, has been almost nonexistent.

Geoffrey Barnes, a cardiovascular specialist at the University of Michigan, said the study's approach and its findings were "striking" in making the case that "the risk with these drugs is real". However, he said that due to the enthusiasm some US citizens have for the drug and The Lancet study's findings, randomized trials are even more important.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 成人亚洲国产 | 午夜久久久久久久 | 国产高清精品一级毛片 | 欧美日韩精品一区二区视频在线观看 | 国内精品久久久久久久aa护士 | 久久一区二区三区免费 | 黄色视影 | 美女性视频网站 | 亚洲精品综合欧美一区二区三区 | 亚洲人成在线影院 | 欧美精品高清在线观看 | 在线观看亚洲专区 | 欧美黑粗特黄午夜大片 | 午夜日韩 | 欧美巨乳在线 | 中国日本高清免费视频网 | 国产在线视频欧美亚综合 | 成人合成mv福利视频网站 | 日本天堂网在线观看 | 91最新地址永久入口 | 国产视频自拍偷拍 | 黄网在线免费 | 性欧美17一18sex性高清播放 | 亚洲精品国产成人专区 | 亚洲天堂在线观看视频 | 亚洲一区二区三区在线视频 | 美女视频免费永久观看的 | 大片国产片日本观看免费视频 | 久久久久久久国产精品影院 | 手机在线观看精品国产片 | 亚洲欧美日韩综合二区三区 | 国产欧美亚洲精品 | 大尺度福利视频奶水在线 | 国内视频一区二区 | 欧美综合亚洲 | 亚洲国产专区 | 人与拘一级a毛片 | 中文国产成人精品久久水 | 国产高清精品自在线看 | 成人在线综合 | 91香蕉国产在线观看免费永久 |